Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
The combination of exposure to chemical solvents at work, having genes associated with MS and smoking greatly increases the risk of developing multiple sclerosis according to new research.
The MS Trust is very disappointed that NICE is unable to recommend ocrelizumab as an NHS treatment for early primary progressive MS.
Paul Kosinski pushed himself out of his comfort zone to take part in our Jump in June skydiving month.
NICE has approved ocrelizumab (Ocrevus) as a treatment for relapsing remitting multiple sclerosis on the NHS in England and Wales.
- NICE say yes to Ocrevus for RRMS
- Review of medical cannabis
- PIP review changes
- Tysabri in SPMS
- Stress linked to MS risk
Many people with MS experience 'cog fog', which is when you sometimes struggle with things like memory, attention span and concentration. In this blog, Helena, who was diagnosed with MS 11 years ago, talks about her own experience of the dreaded cog fog, and why she's determined those 'fuzzy brain days' won't stop her doing the things she loves.
On September 5, 2017, the MS Trust announced that it would be working with NHS Lanarkshire to improve access to MS nurses in the area, and ensure people living with MS get the support they need. Nine months on, we're pleased to report on the positive difference the new MS nurses have made to people with MS in Lanarkshire.
- School project explores MS
- Tecfidera and Gilenya compared
- Ocrevus delays progression
- Ocrevus in PPMS - new trial announced
- Obesity and smoking and risk of MS
- Family support helps
An MS diagnosis left Phil feeling ‘stunned and scared’, but writing about some of the emotions he experienced in a poem helped him come to terms with the diagnosis.
Jo Sopala, Director of Health Professional Programmes at the MS Trust, has signed up to run the British 10K in July and wants you to join her.
The weather's picked up, the BBQs are out and the ice-cream van is making its tuneful way up our road. This can only mean one thing: the holidays are hurtling towards us. As a general rule, breaks away are meant to be a relaxing experience. But when MS comes as part of the package deal, this isn't always the case. Caroline, who blogs at Mildly Scrambled, was diagnosed 14 years ago and has picked up a few holidaying tips along the way.
- NICE approves injectable drugs for relapsing MS
- Gilenya approved for young Americans
- AAN meeting round up
- RCN supports medical cannabis
- Vitamins and dietary supplements
We'd like to wish the best of luck to longstanding MS Trust supporter Jim Thompson as he begins a 1,300 mile trek.
Having kept her MS secret for eight years, MS Trust supporter Jenna decided to open up about life with the condition earlier this year – and says it was the best decision she’s ever made. Here she tells us about the empowerment she felt sharing her story and raising awareness of MS.
NICE approves Avonex, Extavia and Rebif, Copaxone and Brabio, does not recommend Betaferon and will assess Plegridy separately.
Lots of you share your views on issues affecting people with MS in the letters and emails you send us, your phone calls and on our social media channels. Here we focus on a couple of burning issues that have got many of you talking.
Caring for a loved one with advanced MS can bring all kinds of challenges, with many families feeling like they have nowhere to turn. Here, we speak to Lisa and Tony Tanner, who care for Lisa’s mum Georgetta, about the ups and downs of being a carer, and how the MS Trust's Advanced MS Champion programme will make a difference.